Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,600
Closed -$40K 3945
2023
Q3
$40K Sell
1,600
-3,200
-67% -$73.2K ﹤0.01% 1623
2023
Q2
$101K Buy
4,800
+3,000
+167% +$56.9K 0.01% 910
2023
Q1
$30K Buy
+1,800
New +$35K ﹤0.01% 1680
2022
Q4
Sell
-1,800
Closed -$38K 4777
2022
Q3
$38K Buy
+1,800
New +$43.2K ﹤0.01% 2098
2020
Q2
Sell
-6,693
Closed -$159K 4610
2020
Q1
$107K Buy
+6,693
New +$159K 0.01% 1301
2019
Q1
Sell
-2,200
Closed -$28K 4371
2018
Q4
$28K Buy
2,200
+1,100
+100% +$17.6K ﹤0.01% 1870
2018
Q3
$22K Sell
1,100
-200
-15% -$4.52K ﹤0.01% 2177
2018
Q2
$30K Buy
+1,300
New +$33.5K ﹤0.01% 1929
2017
Q4
Sell
-4,639
Closed -$137K 5357
2017
Q3
$144K Buy
4,639
+3,139
+209% +$59.8K 0.01% 1393
2017
Q2
$25K Sell
1,500
-6,065
-80% -$104K ﹤0.01% 3189
2017
Q1
$132K Buy
7,565
+7,265
+2,422% +$112K 0.01% 1495
2016
Q4
$3K Buy
+300
New +$4.09K ﹤0.01% 5318
2016
Q3
Sell
-1,200
Closed -$15K 6988
2016
Q2
$11K Buy
1,200
+600
+100% +$7K ﹤0.01% 4023
2016
Q1
$7K Sell
600
-4,967
-89% -$65.3K ﹤0.01% 4481
2015
Q4
$101K Buy
+5,567
New +$98.1K 0.01% 1762

Other funds holding INSM

Cutler Group's INSM Position: Q4 2023 in Review

Cutler Group sold out of Insmed (INSM) in Q4 2023, closing a stake of 1,600 shares — an estimated $40K sold.

Cutler Group first reported a position in INSM in Q4 2015 and held it in 15 quarters. The position peaked at $144K in Q3 2017. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

  • Cutler Group reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,600 Insmed shares in Q4 2023, an estimated $40K.
  • Cutler Group first reported a position in Insmed in Q4 2015 and held it in 15 quarters.
  • Cutler Group's Insmed position peaked at $144K in Q3 2017.
  • 271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.